Clinical trial
Effect of Valsartan on Proteinuria in Patients With Hypertension and Diabetes…
NCT00241085 · Novartis, Industry · Completed
Key facts
| NCT number | NCT00241085 |
|---|---|
| Title | Effect of Valsartan on Proteinuria in Patients With Hypertension and Diabetes Mellitus |
| Official title | A Multi-center, Double Blind, Randomized, Parallel Group Study to Evaluate the Effects of Valsartan on Proteinuria in Hypertensive Subjects With Type 2 Diabetes Mellitus |
| Lead sponsor | Novartis, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | PROTEINURIA, Hypertension, Type 2 Diabetes |
| Intervention type | Drug |
| Interventions | valsartan |
| Enrollment | 392 |
| Start date | Nov 1, 2002 |
| Primary completion | Aug 1, 2005 |
| Completion | Aug 1, 2005 |
| First posted | Oct 18, 2005 |
| Last update posted | Nov 8, 2011 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: